Evidence map›Paper›PMID 38169900›Full record

ArticleJHEP reports : innovation in hepatology2024

Development and optimisation of a reception testing protocol designed to eliminate HCV in the UK prison population.

Emily Mongale, Samantha Allen, Iain Brew, Arran Ludlow-Rhodes, Nichola Royal, Julia Waldron, Hannah Alexander, Lee Christensen, Kate Dorrington, Andrew Milner and 3 more

Open access · goldAbstract read
In one paragraph

Article in JHEP reports : innovation in hepatology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
1.2field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it, 6 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 3 institutions in 1 country.

Emily MongalePractice Plus Group, 5-6 Napier Court, Napier Road, Berkshire RG1 8BW, UK.
Samantha AllenPractice Plus Group, 5-6 Napier Court, Napier Road, Berkshire RG1 8BW, UK.
Iain BrewPractice Plus Group, 5-6 Napier Court, Napier Road, Berkshire RG1 8BW, UK.
Arran Ludlow-RhodesPractice Plus Group, 5-6 Napier Court, Napier Road, Berkshire RG1 8BW, UK.
Nichola RoyalPractice Plus Group, 5-6 Napier Court, Napier Road, Berkshire RG1 8BW, UK.
Julia WaldronPractice Plus Group, 5-6 Napier Court, Napier Road, Berkshire RG1 8BW, UK.
Hannah AlexanderPractice Plus Group, 5-6 Napier Court, Napier Road, Berkshire RG1 8BW, UK.
Lee ChristensenThe Hepatitis C Trust, 27 Crosby Row, London SE1 3YD, UK.
Kate DorringtonGilead Sciences Ltd, 280 High Holborn, London WC1V 7EE, UK.
Andrew MilnerGilead Sciences Ltd, 280 High Holborn, London WC1V 7EE, UK.
Louise MissenGilead Sciences Ltd, 280 High Holborn, London WC1V 7EE, UK.
Andy JonesGilead Sciences Ltd, 280 High Holborn, London WC1V 7EE, UK.
Philip J F TrokeGilead Sciences Ltd, 280 High Holborn, London WC1V 7EE, UK.
Edinburgh Napier University · GBGilead Sciences (United Kingdom) · GBThe Hepatitis C Trust · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background & Aims: Micro-elimination of hepatitis C virus (HCV) in high-risk populations is a feasible approach towards achieving the World Health Organization's targets for viral hepatitis elimination by 2030. Prisons represent an area of high HCV prevalence and so initiatives that improve testing and treatment of residents are needed to eliminate HCV from prisons. This initiative aimed to improve the HCV screening and treatment rates of new residents arriving at prisons in England. Methods: A rapid test and treat pathway was developed and implemented in 47 prisons in England between May 2019 and October 2021 as a healthcare service improvement initiative. Prison healthcare staff performed opt-out HCV testing for all new residents at each prison within 7 days of arrival, and those who were positive for HCV RNA were offered treatment with direct-acting antivirals (DAAs). The Hepatitis C Trust provided peer support for all residents on treatment and those who were released into the community. Results: Of 107,260 new arrivals, 98,882 (92.2%) were offered HCV antibody testing, 63,137 (63.9%) were tested and 1,848 were treated. Testing rates increased from 53.7% in Year 1 to 86.0% in Year 3. Between May 2020 and October 2021, 40,727 residents were tested, 2,286 residents were positive for HCV antibodies and 940 residents were HCV RNA positive, giving an antibody prevalence of 5.6% and an RNA prevalence of 2.3%. A total of 921 residents were referred for treatment and 915 initiated DAA treatment (97.3% of whom were HCV RNA positive). Conclusions: This initiative showed that an opt-out HCV test and treat initiative in prison receptions is feasible and can be adapted to the needs of individual prisons as a viable way to achieve HCV micro-elimination. Impact and implications: Prisons represent an area of high HCV prevalence and so initiatives that improve testing and treatment of residents are needed to eliminate HCV from prisons. The reception testing protocol improved HCV screening in new arrivals across 47 prisons in England and could be a viable way for countries to achieve HCV micro-elimination in their prison systems. The reception testing protocol presented here can be adapted to the individual needs of prisons, globally, to improve HCV screening and treatment in this setting.

Indexed as

Direct-acting antiviralEliminationHepatitis CNurse-ledPeersPrisonScreening

Identifiers

PMID38169900
PMCPMC10758963
OpenAlexW4387674857

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.